MNMD (Mind Medicine (MindMed) Inc.) Stock Market Reviews

crown

search

Read and share opinions on MNMD (Mind Medicine (MindMed) Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

MNMD

Mind Medicine (MindMed) Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

MindMed (MNMD): Evaluating Valuation After Recent Share Price Momentum Cools
Nov 9, 2025
Mind Medicine Inc (MNMD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ...
Nov 7, 2025
MindMed Reports Q3 2025 Financial Results and Business Updates
Nov 6, 2025
MindMed to Participate in Upcoming Investor Conferences
Nov 5, 2025
MindMed Announces New Employee Inducement Grant
Nov 3, 2025
Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Nov 3, 2025
MindMed to Report Q3 2025 Financial Results on November 6, 2025
Oct 30, 2025
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
Oct 30, 2025
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
Oct 29, 2025
MindMed Announces New Employee Inducement Grants
Sep 22, 2025
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
Sep 19, 2025
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
Sep 4, 2025
Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment
Sep 2, 2025
MindMed to Participate in September Investor Conferences
Aug 28, 2025

Reviews